Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study on Consumer Responses to Labeling Statements on Food Packages, 20675-20677 [2011-8908]
Download as PDF
mstockstill on DSKH9S0YB1PROD with NOTICES
Federal Register / Vol. 76, No. 71 / Wednesday, April 13, 2011 / Notices
Services announces OHS Tribal
Consultations for leaders of Tribal
Governments operating Head Start and
Early Head Start programs in Regions I,
II, IV, and VI. The Consultation Session
for Region VI will take place Friday,
April 29, 2011, at the Indian Pueblo
Cultural Center in Albuquerque, New
Mexico, immediately following the
Department of Health and Human
Services Regional Consultations session.
The Consultation Session for Regions I,
II, and IV will take place Thursday, May
19, 2011, at the Paragon Casino Resort
in Marksville, Louisiana, immediately
following the United South and Eastern
Tribes, Inc. 2011 Semi-annual Meeting.
We are convening the OHS Tribal
Consultations in conjunction with other
Tribal Leader events in order to
minimize the financial and travel
burden for participants.
The agendas for both scheduled OHS
Tribal Consultations will be organized
around the statutory purposes of Head
Start Tribal Consultations related to
meeting the needs of American Indian
and Alaska Native children and
families, taking into consideration
funding allocations, distribution
formulas, and other issues affecting the
delivery of Head Start services in their
geographic locations. In addition, OHS
will share actions taken and in progress
to address the issues and concerns
raised in 2010 OHS Tribal
Consultations.
Tribal leaders and designated
representatives interested in submitting
written testimony or proposing specific
agenda topics for the Albuquerque or
Marksville Consultation Sessions
should contact Camille Loya at
Camille.Loya@acf.hhs.gov at least three
days in advance of the Session.
Proposals should include a brief
description of the topic area along with
the name and contact information of the
suggested presenter.
The Consultation Sessions will be
conducted with elected or appointed
leaders of Tribal Governments and their
designated representatives [42
U.S.C.9835, Section 640(l)(4)(A)].
Designees must have a letter from the
Tribal Government authorizing them to
represent the Tribe. The letter should be
submitted at least three days in advance
of the Consultation Session to Camille
Loya at (202) 205–9721 (fax). Other
representatives of Tribal organizations
and Native nonprofit organizations are
welcome to attend as observers.
A detailed report of each Consultation
Session will be prepared and made
available within 90 days of the
Consultation Session to all Tribal
Governments receiving funds for Head
Start and Early Head Start programs.
VerDate Mar<15>2010
18:37 Apr 12, 2011
Jkt 223001
Tribes wishing to submit written
testimony for the report should send
testimony to Camille Loya at
Camille.Loya@acf.hhs.gov either prior to
the Consultation Session or within 30
days after the meeting.
Oral testimony and comments from
the Consultation Session will be
summarized in the report without
attribution, along with topics of concern
and recommendations. Hotel and
logistical information for all
Consultation Sessions has been sent to
Tribal leaders via e-mail and posted on
the Head Start Resource Center Web site
at https://
www.headstartresourcecenter.org.
Dated: April 6, 2011.
Ann Linehan,
Deputy Director, Office of Head Start.
[FR Doc. 2011–8999 Filed 4–12–11; 8:45 am]
BILLING CODE 4184–40–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0221]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Experimental
Study on Consumer Responses to
Labeling Statements on Food
Packages
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
a study entitled ‘‘Experimental Study on
Consumer Responses to Labeling
Statements on Food Packages.’’
DATES: Submit either electronic or
written comments on the collection of
information by June 13, 2011.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852. All
SUMMARY:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
20675
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
3793.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined in
44 U.S.C. 3502(3) and 5 CFR 1320.3(c)
and includes Agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires Federal Agencies
to provide a 60-day notice in the
Federal Register concerning each
proposed collection of information
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Experimental Study on Consumer
Responses to Labeling Statements on
Food Packages; 21 U.S.C. 393(d)(2)(C)—
(OMB 0910–NEW)
I. Background
The Nutrition Labeling and Education
Act requires almost all packaged foods
to bear nutrition labeling in the form of
the Nutrition Facts label. The law also
allows manufacturers to provide other
nutrition information on labels in the
form of various types of statements,
including claims, as long as such
statements comply with the regulatory
limits that govern the use of each type
of statement. There are three types of
E:\FR\FM\13APN1.SGM
13APN1
mstockstill on DSKH9S0YB1PROD with NOTICES
20676
Federal Register / Vol. 76, No. 71 / Wednesday, April 13, 2011 / Notices
claims that the food industry can
voluntarily use on food labels: (1)
Health claims, (2) nutrient content
claims (e.g., ‘‘Low fat’’), and (3)
structure/function claims (e.g., ‘‘Calcium
builds strong bones.’’). There are three
types of health claims: (1) Those that
meet the Significant Scientific Standard
(e.g., ‘‘Adequate calcium and Vitamin D
throughout life, as part of a wellbalanced diet, may reduce the risk of
osteoporosis.’’), (2) those that are based
on authoritative statements from a
recognized scientific body of the U.S.
government or the National Academy of
Sciences (e.g., ‘‘Diets containing foods
that are a good source of potassium and
that are low in sodium may reduce the
risk of high blood pressure and stroke.’’),
and (3) qualified health claims that are
granted under enforcement discretion
(e.g., ‘‘Supportive but not conclusive
research shows that consumption of
EPA and DHA omega-3 fatty acids may
reduce the risk of coronary heart
disease. One serving of [Name of the
food] provides [ ] grams of EPA and
DHA omega-3 fatty acids. [See nutrition
information for total fat, saturated fat,
and cholesterol content.]’’). Although
the different types of claims are
regulated differently, they all must be
truthful and not misleading (Ref. 1).
With the increased public interest in
identifying healthier foods, U.S. food
processors have been adding nutritional
information in the form of nutrition
symbols to food labels in addition to
claims. Examples of nutrition symbols
that have been or are planned to be used
on food labels include nutrient-specific
disclosure (e.g., ‘‘Guideline Daily
Amounts’’) (Ref. 2), calorie declaration
(Ref. 3), summary product rating (e.g.,
‘‘Smart Spot’’) (Ref. 4), and a hybrid
summary indicator with nutrientspecific disclosure (e.g., ‘‘Sensible
Solution: Good Source of Calcium, Good
Sources of 8 Vitamins and Minerals’’)
(Ref. 5). Claims related to nonnutritional product characteristics are
also used in food labeling. The claims
may feature, among other things,
statements about how foods are grown
or made (e.g., ‘‘Organic’’ and ‘‘All
Natural’’) or absence of a substance (e.g.,
‘‘Gluten-free’’).
Many consumers use claims and the
Nutrition Facts label in food choice
decisions (Refs. 6 through 8). While
some products carry only a single
labeling statement (e.g., either one claim
or one symbol) on their packages, many
products carry two or more labeling
statements. In addition, on the same
package the attributes of one statement
may differ from those of other
statements in terms of featured nutrient,
type of claim, framing of statement,
VerDate Mar<15>2010
18:37 Apr 12, 2011
Jkt 223001
nature of statement, and presentation of
statement. For example, a package may
display one or more statements such as
symbols relating to nutrition content,
statements in words relating to the
presence of certain nutrients, statements
in words relating to the absence of other
nutrients, statements in words relating
the health benefits of consuming foods
containing or not containing certain
other nutrients, and statements in words
describing how the product was
produced. Moreover, all of those
symbols and statements are distributed
in various places on the package in
different font sizes and colors.
There exists a large body of literature
on the impacts of different types of
labeling statements on consumer
perceptions and choices of products
(Refs. 9 and 10). The majority of the
research, including the consumer
research that the Agency has previously
conducted (Refs. 11 and 12), has
focused on single labeling statements by
eliciting study participants’ reactions to
variants of a given statement. An
advantage of this research approach is
that it helps isolate the effects of
individual statements and avoid
potential confounding effects caused by
the presence of other statements. A
disadvantage of this research approach,
however, is that it does not necessarily
reflect the labels consumers see in the
marketplace. In particular, the existing
literature provides little information
about how the coexistence of two or
more different labeling statements
affects product perceptions and choices.
This information, however, is critical for
understanding the roles played by
labeling statements in dietary decisions.
Research suggests consumer product
perceptions and purchase decisions can
be influenced by labeling statements
and different labeling statements may
have different influences (Refs. 9
through 12). Therefore, the FDA, as part
of its effort to promote public health,
proposes to use this study to explore
consumer responses to food labels that
bear multiple labeling statements.
Specifically, the study plans to examine:
(1) Consumer responses to food labels
that exhibit various combinations of the
characteristics of labeling statements
(i.e., nutrients, types of claim, framing of
statement, nature of statement, and
presentation of statement), (2) whether
and how consumer responses to one of
the characteristics may be affected by
other characteristics (i.e., the
interactions between different
characteristics of labeling statements),
and (3) whether and how labeling
statements affect the use of the Nutrition
Facts label.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
The proposed collection of
information is a controlled randomized
experimental study. The study will use
a 15-minute Web-based survey to collect
information from 4,000 Englishspeaking adult members of an online
consumer panel maintained by a
contractor. The study will aim to
produce a sample that reflects the U.S.
Census on gender, education, age, and
ethnicity/race.
The study will randomly assign each
of its participants to view two label
images from a set of food labels that will
be created for the study and
systematically varied in the (1) number
of statements (none, one, or two); (2)
featured nutrient and substance (e.g.,
fat, sodium, sugars, fiber, whole grain,
calories, antioxidant vitamins, or
allergen); (3) type of statement (text or
graphic, specifically the Guideline Daily
Amounts nutrition symbol); (4) framing
of statement (‘‘good source of,’’ ‘‘low,’’ or
‘‘free’’); (5) nature of statement (nutrition
or method of production such as
‘‘natural’’); (6) type size of statement
(large or small); and (7) featured product
(e.g., snacks, breakfast cereals, breads,
soups, or frozen meals). With regard to
claims, the study will focus on
examples of nutrient content claims and
structure/function claims, which can be
found on many food packages (Ref. 13).
All label images will be mock-ups
resembling food labels that may be
found in the marketplace. Images will
show product identity (e.g., potato
chips), but not any real or fictitious
brand name. The study will provide
interested participants access to the
Nutrition Facts label, but not together
with a product image.
The survey will ask its participants to
view label images and answer questions
about their perceptions and reactions
related to the viewed product and label.
Product perceptions (e.g., healthiness,
potential health benefits, levels of
nutrients and substances, taste, and
safety) and label perceptions (e.g.,
helpfulness and credibility) will
constitute the measures of responses in
the experiment. To help understand the
data, the survey will also collect
information about participants’
background, such as consumption,
purchase, perception, and familiarity
with a category of food; awareness and
knowledge of nutrients and substances;
dietary interests; motivation regarding
label use and health literacy; and health
status and demographic characteristics.
The study is part of the Agency’s
continuing effort to enable consumers to
make informed dietary choices and
construct healthful diets. Results of the
study will be used primarily to enrich
the Agency’s understanding of how
E:\FR\FM\13APN1.SGM
13APN1
20677
Federal Register / Vol. 76, No. 71 / Wednesday, April 13, 2011 / Notices
multiple claims and other labeling
statements on food packages may affect
how consumers perceive a product or a
label, which may in turn affect their
dietary choices. Results of the study will
not be used to develop population
estimates.
To help design and refine the
questionnaire, FDA plans to conduct
cognitive interviews by screening 72
panelists in order to obtain 9
participants in the interviews. Each
screening is expected to take 5 minutes
(0.083 hour) and each cognitive
interview is expected to take 1 hour.
The total for cognitive interview
activities is 15 hours (6 hours + 9
hours). Subsequently, we plan to
conduct pretests of the questionnaire
before it is administered in the study.
We expect that 1,600 invitations, each
taking 2 minutes (0.033 hour), will need
to be sent to panelists to have 200 of
them complete a 15-minute (0.25 hour)
pretest. The total for the pretest
activities is 106 hours (53 hours + 50
hours). For the survey, we estimate that
32,000 invitations, each taking 2
minutes (0.033 hour) to complete, will
need to be sent to the consumer panel
to have 3,000 of its members complete
a 15-minute (0.25 hour) questionnaire.
The total for the survey activities is
2,056 hours (1,056 hours + 1,000 hours).
Thus, the total estimated burden is
2,174 hours. FDA’s burden estimate is
based on prior experience with research
that is similar to this proposed study.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Portion of study
Number of
responses per
respondent
Total annual
responses
Average
burden per
response
(in hours)
Total hours
Cognitive interview screener ................................................
Cognitive interview ...............................................................
Pretest invitation ..................................................................
Pretest ..................................................................................
Survey invitation ...................................................................
Survey ..................................................................................
72
9
1,600
200
32,000
4,000
1
1
1
1
1
1
72
9
1,600
200
32,000
4,000
5/60
1
2/60
15/60
2/60
15/60
6
9
53
50
1,056
1,000
Total ..............................................................................
........................
........................
........................
........................
2,174
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
II. References
mstockstill on DSKH9S0YB1PROD with NOTICES
The following references have been
placed on display in the Division of
Dockets Management (see ADDRESSES)
and may be seen by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday. (FDA has verified the
Web site addresses, but we are not
responsible for any subsequent changes
to the Web site after this document
publishes in the Federal Register.)
1. U.S. Food and Drug Administration.
Claims That Can Be Made for
Conventional Foods and Dietary
Supplements. September 2003. Available
at https://www.fda.gov/Food/
LabelingNutrition/LabelClaims/
ucm111447.htm.
2. Kellogg’s. Nutrition at a Glance. 2010.
Available at https://
www.kelloggnutrition.com/learn-aboutlabels/nutrition-at-a-glance.html.
3. PepsiCo. Nutrition Labeling. 2010.
Available at https://www.pepsico.com/
Purpose/Human-Sustainability/
Nutrition-Labeling.html.
4. Schmit, J. ‘‘PepsiCo Labels Some of Its
Products ‘Smart,’’’ USA Today,
September 2, 2004. Available at https://
www.usatoday.com/money/industries/
food/2004–09–02-smart-spot_x.htm.
5. Kraft Foods. Sensible Solution. 2010.
Available at https://
www.kraftrecipes.com/kf/HealthyLiving/
SensibleSolution/
SensibleSolution_Landing.aspx.
6. Centers for Disease Control and
Prevention. 2005–2006 National Health
and Examination Survey questionnaire,
VerDate Mar<15>2010
18:37 Apr 12, 2011
Jkt 223001
Diet Behavior and Nutrition section.
Unpublished results of questions
DBQ.750 and DBQ.780. Questionnaire is
available at https://www.cdc.gov/nchs/
data/nhanes/nhanes_05_06/
sp_dbq_d.pdf.
7. U.S. Food and Drug Administration. 2008
Health and Diet Survey. March 20, 2010.
Available at https://www.fda.gov/Food/
ScienceResearch/ResearchAreas/
ConsumerResearch/ucm193895.htm.
8. Food Marketing Institute. 2009 U.S.
Grocery Shopper Trends Survey.
Washington, DC 2009.
9. Drichoutis, A.C., Lazaridis, P. and Nayga,
R.M., ‘‘Consumers’ Use of Nutritional
Labels: a Review of Research Studies and
Issues,’’ Academy of Marketing Science
Review, 2006(9), 2006. Available at
https://www.amsreview.org/articles/
drichoutis09-2006.pdf.
¨
¨
10. Lahteenmaki, L., Lampila, P.. Grunert, K.,
˚
¨
Boztug, Y., Ueland, ;., Astrom, A. and
´
Martinsdottir, E., ‘‘Impact of HealthRelated Claims on the Perception of
Other Product Attributes,’’ Food Policy,
23: 230–9. 2010.
11. Labiner-Wolfe, J., Lin, C.-T. J. and Verrill
L., ‘‘Effect of Low Carbohydrate Claims
on Consumer Perceptions about Food
Products’ Healthfulness and Helpfulness
for Weight Management,’’ Journal of
Nutrition Education and Behavior, 42(5):
315–320, 2010.
12. Roe, B., Levy, A.S., and Derby, B.M., ‘‘The
Impact of Health Claims on Consumer
Search and Product Evaluation
Outcomes: Evidence from FDA
Experimental Data,’’ Journal of Public
Policy and Marketing, 18(1): 89–105,
1999.
13. LeGault, L., Brandt, M.B., McCabe, N.,
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Adler, C., Brown, A.-M., and Brecher, S.,
‘‘2000–2001 Food Label and Package
Survey: An Update on Prevalence of
Nutrition Labeling and Claims on
Processed, Packaged Foods,’’ Journal of
the American Dietetic Association,
104(6): 952–8, 2004.
Dated: April 8, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–8908 Filed 4–12–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0237]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Applications for
Food and Drug Administration
Approval To Market a New Drug;
Postmarketing Reports; Reporting
Information About Authorized Generic
Drugs
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
SUMMARY:
E:\FR\FM\13APN1.SGM
13APN1
Agencies
[Federal Register Volume 76, Number 71 (Wednesday, April 13, 2011)]
[Notices]
[Pages 20675-20677]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8908]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0221]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Experimental Study on Consumer Responses to Labeling
Statements on Food Packages
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal Agencies are required to publish notice in the
Federal Register concerning each proposed collection of information and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on a study entitled ``Experimental Study on
Consumer Responses to Labeling Statements on Food Packages.''
DATES: Submit either electronic or written comments on the collection
of information by June 13, 2011.
ADDRESSES: Submit electronic comments on the collection of information
to https://www.regulations.gov. Submit written comments on the
collection of information to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket
number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Denver Presley, Office of Information
Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B,
Rockville, MD 20850, 301-796-3793.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information before
submitting the collection to OMB for approval. To comply with this
requirement, FDA is publishing notice of the proposed collection of
information set forth in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.
Experimental Study on Consumer Responses to Labeling Statements on Food
Packages; 21 U.S.C. 393(d)(2)(C)--(OMB 0910-NEW)
I. Background
The Nutrition Labeling and Education Act requires almost all
packaged foods to bear nutrition labeling in the form of the Nutrition
Facts label. The law also allows manufacturers to provide other
nutrition information on labels in the form of various types of
statements, including claims, as long as such statements comply with
the regulatory limits that govern the use of each type of statement.
There are three types of
[[Page 20676]]
claims that the food industry can voluntarily use on food labels: (1)
Health claims, (2) nutrient content claims (e.g., ``Low fat''), and (3)
structure/function claims (e.g., ``Calcium builds strong bones.'').
There are three types of health claims: (1) Those that meet the
Significant Scientific Standard (e.g., ``Adequate calcium and Vitamin D
throughout life, as part of a well-balanced diet, may reduce the risk
of osteoporosis.''), (2) those that are based on authoritative
statements from a recognized scientific body of the U.S. government or
the National Academy of Sciences (e.g., ``Diets containing foods that
are a good source of potassium and that are low in sodium may reduce
the risk of high blood pressure and stroke.''), and (3) qualified
health claims that are granted under enforcement discretion (e.g.,
``Supportive but not conclusive research shows that consumption of EPA
and DHA omega-3 fatty acids may reduce the risk of coronary heart
disease. One serving of [Name of the food] provides [ ] grams of EPA
and DHA omega-3 fatty acids. [See nutrition information for total fat,
saturated fat, and cholesterol content.]''). Although the different
types of claims are regulated differently, they all must be truthful
and not misleading (Ref. 1).
With the increased public interest in identifying healthier foods,
U.S. food processors have been adding nutritional information in the
form of nutrition symbols to food labels in addition to claims.
Examples of nutrition symbols that have been or are planned to be used
on food labels include nutrient-specific disclosure (e.g., ``Guideline
Daily Amounts'') (Ref. 2), calorie declaration (Ref. 3), summary
product rating (e.g., ``Smart Spot'') (Ref. 4), and a hybrid summary
indicator with nutrient-specific disclosure (e.g., ``Sensible Solution:
Good Source of Calcium, Good Sources of 8 Vitamins and Minerals'')
(Ref. 5). Claims related to non-nutritional product characteristics are
also used in food labeling. The claims may feature, among other things,
statements about how foods are grown or made (e.g., ``Organic'' and
``All Natural'') or absence of a substance (e.g., ``Gluten-free'').
Many consumers use claims and the Nutrition Facts label in food
choice decisions (Refs. 6 through 8). While some products carry only a
single labeling statement (e.g., either one claim or one symbol) on
their packages, many products carry two or more labeling statements. In
addition, on the same package the attributes of one statement may
differ from those of other statements in terms of featured nutrient,
type of claim, framing of statement, nature of statement, and
presentation of statement. For example, a package may display one or
more statements such as symbols relating to nutrition content,
statements in words relating to the presence of certain nutrients,
statements in words relating to the absence of other nutrients,
statements in words relating the health benefits of consuming foods
containing or not containing certain other nutrients, and statements in
words describing how the product was produced. Moreover, all of those
symbols and statements are distributed in various places on the package
in different font sizes and colors.
There exists a large body of literature on the impacts of different
types of labeling statements on consumer perceptions and choices of
products (Refs. 9 and 10). The majority of the research, including the
consumer research that the Agency has previously conducted (Refs. 11
and 12), has focused on single labeling statements by eliciting study
participants' reactions to variants of a given statement. An advantage
of this research approach is that it helps isolate the effects of
individual statements and avoid potential confounding effects caused by
the presence of other statements. A disadvantage of this research
approach, however, is that it does not necessarily reflect the labels
consumers see in the marketplace. In particular, the existing
literature provides little information about how the coexistence of two
or more different labeling statements affects product perceptions and
choices. This information, however, is critical for understanding the
roles played by labeling statements in dietary decisions.
Research suggests consumer product perceptions and purchase
decisions can be influenced by labeling statements and different
labeling statements may have different influences (Refs. 9 through 12).
Therefore, the FDA, as part of its effort to promote public health,
proposes to use this study to explore consumer responses to food labels
that bear multiple labeling statements. Specifically, the study plans
to examine: (1) Consumer responses to food labels that exhibit various
combinations of the characteristics of labeling statements (i.e.,
nutrients, types of claim, framing of statement, nature of statement,
and presentation of statement), (2) whether and how consumer responses
to one of the characteristics may be affected by other characteristics
(i.e., the interactions between different characteristics of labeling
statements), and (3) whether and how labeling statements affect the use
of the Nutrition Facts label.
The proposed collection of information is a controlled randomized
experimental study. The study will use a 15-minute Web-based survey to
collect information from 4,000 English-speaking adult members of an
online consumer panel maintained by a contractor. The study will aim to
produce a sample that reflects the U.S. Census on gender, education,
age, and ethnicity/race.
The study will randomly assign each of its participants to view two
label images from a set of food labels that will be created for the
study and systematically varied in the (1) number of statements (none,
one, or two); (2) featured nutrient and substance (e.g., fat, sodium,
sugars, fiber, whole grain, calories, antioxidant vitamins, or
allergen); (3) type of statement (text or graphic, specifically the
Guideline Daily Amounts nutrition symbol); (4) framing of statement
(``good source of,'' ``low,'' or ``free''); (5) nature of statement
(nutrition or method of production such as ``natural''); (6) type size
of statement (large or small); and (7) featured product (e.g., snacks,
breakfast cereals, breads, soups, or frozen meals). With regard to
claims, the study will focus on examples of nutrient content claims and
structure/function claims, which can be found on many food packages
(Ref. 13). All label images will be mock-ups resembling food labels
that may be found in the marketplace. Images will show product identity
(e.g., potato chips), but not any real or fictitious brand name. The
study will provide interested participants access to the Nutrition
Facts label, but not together with a product image.
The survey will ask its participants to view label images and
answer questions about their perceptions and reactions related to the
viewed product and label. Product perceptions (e.g., healthiness,
potential health benefits, levels of nutrients and substances, taste,
and safety) and label perceptions (e.g., helpfulness and credibility)
will constitute the measures of responses in the experiment. To help
understand the data, the survey will also collect information about
participants' background, such as consumption, purchase, perception,
and familiarity with a category of food; awareness and knowledge of
nutrients and substances; dietary interests; motivation regarding label
use and health literacy; and health status and demographic
characteristics.
The study is part of the Agency's continuing effort to enable
consumers to make informed dietary choices and construct healthful
diets. Results of the study will be used primarily to enrich the
Agency's understanding of how
[[Page 20677]]
multiple claims and other labeling statements on food packages may
affect how consumers perceive a product or a label, which may in turn
affect their dietary choices. Results of the study will not be used to
develop population estimates.
To help design and refine the questionnaire, FDA plans to conduct
cognitive interviews by screening 72 panelists in order to obtain 9
participants in the interviews. Each screening is expected to take 5
minutes (0.083 hour) and each cognitive interview is expected to take 1
hour. The total for cognitive interview activities is 15 hours (6 hours
+ 9 hours). Subsequently, we plan to conduct pretests of the
questionnaire before it is administered in the study. We expect that
1,600 invitations, each taking 2 minutes (0.033 hour), will need to be
sent to panelists to have 200 of them complete a 15-minute (0.25 hour)
pretest. The total for the pretest activities is 106 hours (53 hours +
50 hours). For the survey, we estimate that 32,000 invitations, each
taking 2 minutes (0.033 hour) to complete, will need to be sent to the
consumer panel to have 3,000 of its members complete a 15-minute (0.25
hour) questionnaire. The total for the survey activities is 2,056 hours
(1,056 hours + 1,000 hours). Thus, the total estimated burden is 2,174
hours. FDA's burden estimate is based on prior experience with research
that is similar to this proposed study.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of Total annual burden per
Portion of study respondents responses per responses response (in Total hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Cognitive interview screener.... 72 1 72 5/60 6
Cognitive interview............. 9 1 9 1 9
Pretest invitation.............. 1,600 1 1,600 2/60 53
Pretest......................... 200 1 200 15/60 50
Survey invitation............... 32,000 1 32,000 2/60 1,056
Survey.......................... 4,000 1 4,000 15/60 1,000
-------------------------------------------------------------------------------
Total....................... .............. .............. .............. .............. 2,174
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
II. References
The following references have been placed on display in the
Division of Dockets Management (see ADDRESSES) and may be seen by
interested persons between 9 a.m. and 4 p.m., Monday through Friday.
(FDA has verified the Web site addresses, but we are not responsible
for any subsequent changes to the Web site after this document
publishes in the Federal Register.)
1. U.S. Food and Drug Administration. Claims That Can Be Made for
Conventional Foods and Dietary Supplements. September 2003.
Available at https://www.fda.gov/Food/LabelingNutrition/LabelClaims/ucm111447.htm.
2. Kellogg's. Nutrition at a Glance. 2010. Available at https://www.kelloggnutrition.com/learn-about-labels/nutrition-at-a-glance.html.
3. PepsiCo. Nutrition Labeling. 2010. Available at https://www.pepsico.com/Purpose/Human-Sustainability/Nutrition-Labeling.html.
4. Schmit, J. ``PepsiCo Labels Some of Its Products `Smart,''' USA
Today, September 2, 2004. Available at https://www.usatoday.com/money/industries/food/2004-09-02-smart-spot_x.htm.
5. Kraft Foods. Sensible Solution. 2010. Available at https://www.kraftrecipes.com/kf/HealthyLiving/SensibleSolution/SensibleSolution_Landing.aspx.
6. Centers for Disease Control and Prevention. 2005-2006 National
Health and Examination Survey questionnaire, Diet Behavior and
Nutrition section. Unpublished results of questions DBQ.750 and
DBQ.780. Questionnaire is available at https://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/sp_dbq_d.pdf.
7. U.S. Food and Drug Administration. 2008 Health and Diet Survey.
March 20, 2010. Available at https://www.fda.gov/Food/ScienceResearch/ResearchAreas/ConsumerResearch/ucm193895.htm.
8. Food Marketing Institute. 2009 U.S. Grocery Shopper Trends
Survey. Washington, DC 2009.
9. Drichoutis, A.C., Lazaridis, P. and Nayga, R.M., ``Consumers' Use
of Nutritional Labels: a Review of Research Studies and Issues,''
Academy of Marketing Science Review, 2006(9), 2006. Available at
https://www.amsreview.org/articles/drichoutis09-2006.pdf.
10. L[auml]hteenm[auml]ki, L., Lampila, P.. Grunert, K., Boztug, Y.,
Ueland, [Oslash]., [Aring]str[ouml]m, A. and Martinsd[oacute]ttir,
E., ``Impact of Health-Related Claims on the Perception of Other
Product Attributes,'' Food Policy, 23: 230-9. 2010.
11. Labiner-Wolfe, J., Lin, C.-T. J. and Verrill L., ``Effect of Low
Carbohydrate Claims on Consumer Perceptions about Food Products'
Healthfulness and Helpfulness for Weight Management,'' Journal of
Nutrition Education and Behavior, 42(5): 315-320, 2010.
12. Roe, B., Levy, A.S., and Derby, B.M., ``The Impact of Health
Claims on Consumer Search and Product Evaluation Outcomes: Evidence
from FDA Experimental Data,'' Journal of Public Policy and
Marketing, 18(1): 89-105, 1999.
13. LeGault, L., Brandt, M.B., McCabe, N., Adler, C., Brown, A.-M.,
and Brecher, S., ``2000-2001 Food Label and Package Survey: An
Update on Prevalence of Nutrition Labeling and Claims on Processed,
Packaged Foods,'' Journal of the American Dietetic Association,
104(6): 952-8, 2004.
Dated: April 8, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-8908 Filed 4-12-11; 8:45 am]
BILLING CODE 4160-01-P